Area of research
Pharmacology · Physiology
Research interest
Research interests include Medicine, Pharmacology, Inflammation, Cannabinoid, Internal medicine, and Cannabinoid receptor.
Perspective on alcohol-induced organ damage via autophagy-dependent cellular changes
PCSK9 inhibition attenuates alcohol-associated neuronal oxidative stress and cellular injury
Chronic alcohol consumption exacerbates ischemia-associated skeletal muscle mitochondrial dysfunction in a murine model of peripheral artery disease
Detection of cannabinoid receptor type 2 in native cells and zebrafish with a highly potent, cell-permeable fluorescent probe
Editorial: Therapeutic potential of the cannabinoid CB2 receptor
Bile acid–activated macrophages promote biliary epithelial cell proliferation through integrin αvβ6 upregulation following liver injury
Loss of acinar cell VMP1 triggers spontaneous pancreatitis in mice
Beyond THC and Endocannabinoids
Impaired TFEB-mediated lysosomal biogenesis promotes the development of pancreatitis in mice and is associated with human pancreatitis
Macrophage P2X4 receptors augment bacterial killing and protect against sepsis
DEP domain–containing mTOR–interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute‐on‐chronic liver injury in alcoholic liver disease
Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in Steatohepatitis
Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity
Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseases
Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury
A Mechanistic Review of Cell Death in Alcohol‐Induced Liver Injury
Cannabidiol Limits T Cell-Mediated Chronic Autoimmune Myocarditis: Implications to Autoimmune Disorders and Organ Transplantation
Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis
Endocannabinoid signaling at the periphery: 50 years after THC
Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis
The novel, orally available and peripherally restricted selective cannabinoid CB<sub>2</sub> receptor agonist LEI‐101 prevents cisplatin‐induced nephrotoxicity
Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy
Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy
Immunity, inflammation and cancer: a leading role for adenosine
Monoacylglycerol Lipase Controls Endocannabinoid and Eicosanoid Signaling and Hepatic Injury in Mice
Cannabinoid 1 Receptor Promotes Cardiac Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in Diabetic Cardiomyopathy
Glucocorticoid receptor dimerization is required for proper recovery of LPS-induced inflammation, sickness behavior and metabolism in mice
Circulating anandamide and blood pressure in patients with obstructive sleep apnea